Heparin promotes suspension adaptation process of CHO-TS28 cells by eliminating cell aggregation

Molecular Biotechnology

Volumn 47, Issue 1, 2011, Pages 9-17

  Li, Ling ^a   Qin, Jun ^b   Feng, Qiang ^a   Tang, Hao ^a   Liu, Rong ^a   Xu, Liqing ^a   Chen, Zhinan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell aggregation; Heparin; Suspension adaptation

Indexed keywords

ADAPTATION PROCESS; ANTIGEN-BINDING ACTIVITIES; CELL AGGREGATES; CELL AGGREGATION; CELL DENSITY; CHIMERIC ANTIBODY; CHINESE HAMSTER OVARY CELLS; CHO CELL; CONCENTRATION-DEPENDENT; HEK293 CELLS; HEPARIN; INHIBITORY EFFECT; POTENTIAL APPLICATIONS; SINGLE-CELL SUSPENSIONS; SUSPENSION ADAPTATION;

ADHESION; AGGLOMERATION; ANCHORAGES (FOUNDATIONS); ANIMAL CELL CULTURE; ANTIBODIES; ANTIGENS; CELL ADHESION; CELL GROWTH; GROWTH KINETICS; PHYSIOLOGY; POLYSACCHARIDES; VIRUSES;

CELL CULTURE;

CHIMERIC ANTIBODY; CHIMERIC ANTIBODY CHAB18; HEPARIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CELL ADHESION; CELL AGGREGATION; CELL ANCHORAGE; CELL DENSITY; CELL GROWTH; CELL STRAIN; CELL STRAIN CHO TS28; CELL SUSPENSION; CHO CELL; CONTROLLED STUDY; GROWTH RATE; HUMAN; NONHUMAN;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CELL ADHESION; CELL AGGREGATION; CELL COUNT; CELL CULTURE TECHNIQUES; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; CULTURE MEDIA, SERUM-FREE; HEPARIN;

CRICETULUS GRISEUS; HEXAPODA;

EID: 79551532048     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12033-010-9306-1     Document Type: Article

References (20)

1. J Xu ZY Shen XG Chen Q Zhang HJ Bian P Zhu, et al. 2007 A randomized controlled trial of LICARTIN for preventing hepatoma recurrence after liver transplantation Hepatology 45 269 276 1:CAS:528:DC%2BD2sXisVKgu74%3D 10.1002/hep.21465 (Pubitemid 46374583)
2. 131I) metuximab injection: Clinical phase I/II trails International Journal of Radiation Oncology, Biology, Physics 65 435 444 1:CAS:528:DC%2BD28XksVCktLc%3D 10.1016/j.ijrobp.2005.12.034
3. Q Feng L Mi L Li R Liu L Xie H Tang, et al. 2006 Application of "oxygen uptake rate-amino acids" associated mode in controlled-fed perfusion culture Journal of Biotechnology 122 422 430 1:CAS:528: DC%2BD28XjtFOmsrY%3D 10.1016/j.jbiotec.2005.09.017
4. L Li L Mi Q Feng R Liu H Tang L Xie, et al. 2006 Stability validations of seed cell quality control parameters in enlarge scale hybridoma cell culture Applied Microbiology and Biotechnology 70 34 39 1:CAS:528:DC%2BD28Xhtlegs7k%3D 10.1007/s00253-005-0047-1 (Pubitemid 43234526)
5. FM Wurm 2004 Production of recombinant protein therapeutics in cultivated mammalian cells Nature Biotechnology 22 1393 1398 1:CAS:528: DC%2BD2cXptlSls7k%3D 10.1038/nbt1026 (Pubitemid 39482858)
6. K Astley M Naciri A Racher M Al-Rubeai 2007 The role of p21cip1 in adaptation of CHO cells to suspension and protein-free culture Journal of Biotechnology 130 282 290 1:CAS:528:DC%2BD2sXmvVKmtb4%3D 10.1016/j.jbiotec.2007. 04.012 (Pubitemid 46920542)
7. Rory, M. (2002). Adaptation of Chinese hamster ovary cells in culture: A literature survey of adhesion proteins. CHEE4006, Individual Inquiry, A, 2-3.
8. N Sinacore T Charlebois S Harrison S Brennan T Richards M Hamilton, et al. 1996 CHO DUKX cell lineages preadapted to growth in serum-free suspension culture enable rapid development of cell culture processes for the manufacture of recombinant proteins Biotechnology and Bioengineering 52 518 528 1:CAS:528:DyaK28Xms1Wktb8%3D 10.1002/(SICI)1097-0290(19961120)52:4<518::AID- BIT7>3.0.CO;2-S (Pubitemid 26354732)
9. HJ Cruz EM Dias JL Moreira MJT Carrondo 1997 Cell-dislodging methods under serum-free conditions Applied Microbiology and Biotechnology 47 482 488 1:CAS:528:DyaK2sXjvVOrsbc%3D 10.1007/s002530050960 (Pubitemid 27272550)
10. K Dee ML Shuler HA Wood 1997 Inducing single-cell suspension of BTI-TN5B1-4 insect cells: I. The use of sulfated polyanions to prevent cell aggregation and enhance recombinant protein production Biotechnology and Bioengineering 54 191 205 1:CAS:528:DyaK2sXivV2jtrg%3D 10.1002/(SICI)1097- 0290(19970505)54:3<191::AID-BIT1>3.0.CO;2-A (Pubitemid 27175110)
11. K Dee HA Wood ML Shuler 1997 Inducing single-cell suspension of BTI-TN5B1-4 insect cells: II. The effect of sulfated polyanions on baculovirusinfection Biotechnology and Bioengineering 54 206 220 1:CAS:528:DyaK2sXivV2jtrk%3D 10.1002/(SICI)1097-0290(19970505)54:3<206::AID- BIT2>3.0.CO;2-J (Pubitemid 27176593)
12. H Nakata 2004 Stimulation of extracellular signal-regulated kinase pathway by suramin with concomitant activation of DNA synthesis in cultured cells Journal of Pharmacology and Experimental Therapeutics 308 744 753 1:CAS:528:DC%2BD2cXhtlWjsr4%3D 10.1124/jpet.103.058230 (Pubitemid 38134239)
13. GA Karam MJ Rasaee M Mahmoodi M Khaksari 2005 Inhibition of proteinase 3 (PR3) by suramin and fetal calf serum (FCS): Effect of PR3 and suramin on Chinese hamster ovary cells (CHO-cells) Pakistan Journal of Pharmaceutical Sciences 18 46 48 1:CAS:528:DC%2BD2MXhtFKktb3M
14. RA Taticek KA McKennac RR Granadosc ML Shuler 1997 Rapid initiation of suspension cultures of Trichoplusia ni insect cells (TN 5B-1-4) using heparin Biotechnological Technique 11 237 240 1:CAS:528:DyaK2sXislaksrk%3D 10.1023/A:1018482304052
15. YS Tsao R Condon E Schaefer P Lio Z Liu 2001 Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells Cytotechnology 37 189 198 1:CAS:528: DC%2BD38XnslGku7Y%3D 10.1023/A:1020555310558 (Pubitemid 35255345)
16. Zhang, S. Y., Thwin, C., Wu, Z., Cho, T. (2001). Method for the production and purification of adenoviral vectors. US Patent, 6194191.
17. Ilkka T Harvima Katriina Lappalainen Maija-Riitta Hirvonen Mikko Mättö Petri K Kivinen Mika Hyttinen, et al. 2004 Heparin modulates the growth and adherence and augments the growth-inhibitory action of TNF-α on cultured human keratinocytes Journal of Cellular Biochemistry 92 372 386 1:CAS:528:DC%2BD2cXjvVaqsb8%3D 10.1002/jcb.20068
18. M Presta D Leali H Stabile R Ronca M Camozzi L Coco, et al. 2003 Heparin derivatives as angiogenesis inhibitors Current Pharmaceutical Design 9 553 566 1:CAS:528:DC%2BD3sXhsVOhs70%3D 10.2174/1381612033391379 (Pubitemid 36221723)
19. CY Lou YM Feng AR Qian Y Li H Tang P Shang ZN Chen 2004 Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98 World Journal of Gastroenterology 10 1462 1465
20. Y Yoshitomia Ho Nakanishib Y Kusanoc S Munesuea K Oguric M Tatematsub, et al. 2004 Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity Cancer Letters 207 165 174 10.1016/j.canlet.2003.11.037 (Pubitemid 38457037)